News

The clinical trial is designed to evaluate the safety, tolerability and efficacy of AT-1001 in 86 subjects during gluten challenge. Patients were randomized into seven drug-treated and placebo

The primary objectives of the phase I clinical trial are to evaluate safety and identify the maximum tolerated dose of L-Annamycin, and to evaluate the antileukemia activity of

The supplemental biologics license application (sBLA) contains the results of a phase III study comparing the hemostatic efficacy of Evicel to standard-of-care in retroperitoneal or intra-abdominal surgery in

This phase II study is commencing as a result of initial positive phase II results indicating that the drug known as TPI ASM8 demonstrated protection in early and

Patients treated with 900mg or 300mg per week doses of Riquent had greater reductions in antibodies than placebo or 100mg per week of Riquent. Following eight weeks of

In the phase III trial patients have been randomized into one of three treatment groups: Gabapentin GR once-daily, Gabapentin GR twice-daily and placebo. The company expects to announce

CVS issued its statement after Express announced that it was raising its $26.1 billion offer for Caremark, as US regulators requested more information on the hostile bid. Express

The phase II trial is also designed to determine the extent of its ability to improve the survival of patients with glioblastoma multiforme, the most common form of

Galapagos said it would supply the small molecule compounds to Johnson & Johnson Pharmaceutical research and development division of Janssen Pharmaceutica. The company said the agreement was a